Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
about
Influenza vaccination in HIV-positive subjects: latest evidence and future perspectiveImmunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.The pandemic influenza A (H1N1) 2009 vaccine does not increase the mortality rate of idiopathic interstitial pneumonia: a matched case-control study.Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccineHeterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant WomenHigh proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth.Immune Responses to Circulating and Vaccine Viral Strains in HIV-Infected and Uninfected Children and Youth Who Received the 2013/2014 Quadrivalent Live-Attenuated Influenza VaccineEffect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetes.Influenza A Virus Infection and Nucleotide Sequencing in HIV-Infected Children: A Case Report and Review of Literature.B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine.
P2860
Q27007483-F9B4FD65-AE98-4281-A887-FF27AC470D88Q30357158-AEA6C5A8-A233-493B-8A10-C1996F95C178Q30359671-88183967-41A4-4C45-A031-E00948FF5862Q30373691-A00B8590-D813-42D3-A64B-B18DA7140406Q30378589-60A1893A-93D9-4461-B84E-F40E1EBB3FC3Q30426654-D3B3EAAC-937C-492C-B88B-BB83F232AEEFQ30426754-69323DAA-5A33-4A2C-8E83-AAA941457110Q34390072-D6CED52D-919D-4764-9074-EBDB83EF1476Q35192297-2C9FA0F2-CB0C-49CA-9D18-A4E9CD1A4741Q36798896-953E38EF-9907-4665-B33A-122EE42AA9D7Q37243204-02E3D753-F394-4962-8332-80B7BC5EA5A6Q40081758-D3A1D618-FAA3-4562-9748-4696B20C10EBQ48505891-4F95ACBE-0B6C-4592-A5CA-A5ACF716829F
P2860
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@ast
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@en
type
label
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@ast
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@en
prefLabel
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@ast
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@en
P2093
P2860
P356
P1476
Safety and immunogenicity of 2 ...... adolescents, and young adults.
@en
P2093
Adriana Weinberg
Anthony Bloom
Barbara Heckman
Coleen K Cunningham
Edward Handelsman
Elizabeth Petzold
George K Siberry
IMPAACT P1088 Team
Judi Miller
L Jill Utech
P2860
P304
P356
10.1093/INFDIS/JIS360
P407
P577
2012-05-21T00:00:00Z